155 related articles for article (PubMed ID: 29878108)
1. Impaired melanocortin pathway function in Prader-Willi syndrome gene-Magel2 deficient mice.
Oncul M; Dilsiz P; Ates Oz E; Ates T; Aklan I; Celik E; Sayar Atasoy N; Atasoy D
Hum Mol Genet; 2018 Sep; 27(18):3129-3136. PubMed ID: 29878108
[TBL] [Abstract][Full Text] [Related]
2. Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader-Willi syndrome.
Pravdivyi I; Ballanyi K; Colmers WF; Wevrick R
Hum Mol Genet; 2015 Aug; 24(15):4276-83. PubMed ID: 25926624
[TBL] [Abstract][Full Text] [Related]
3.
Choi Y; Min HY; Hwang J; Jo YH
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 36007929
[TBL] [Abstract][Full Text] [Related]
4. Magel2 is required for leptin-mediated depolarization of POMC neurons in the hypothalamic arcuate nucleus in mice.
Mercer RE; Michaelson SD; Chee MJ; Atallah TA; Wevrick R; Colmers WF
PLoS Genet; 2013; 9(1):e1003207. PubMed ID: 23341784
[TBL] [Abstract][Full Text] [Related]
5. The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.
Wijesuriya TM; De Ceuninck L; Masschaele D; Sanderson MR; Carias KV; Tavernier J; Wevrick R
Hum Mol Genet; 2017 Nov; 26(21):4215-4230. PubMed ID: 28973533
[TBL] [Abstract][Full Text] [Related]
6. Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.
Bischof JM; Van Der Ploeg LH; Colmers WF; Wevrick R
Br J Pharmacol; 2016 Sep; 173(17):2614-21. PubMed ID: 27339818
[TBL] [Abstract][Full Text] [Related]
7. Dopamine pathway imbalance in mice lacking Magel2, a Prader-Willi syndrome candidate gene.
Luck C; Vitaterna MH; Wevrick R
Behav Neurosci; 2016 Aug; 130(4):448-59. PubMed ID: 27254754
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Prader-Willi Syndrome gene MAGEL2 in severe childhood-onset obesity.
O'Neill MA; Farooqi IS; Wevrick R
Obes Res; 2005 Oct; 13(10):1841-2. PubMed ID: 16286533
[TBL] [Abstract][Full Text] [Related]
9. Muscle dysfunction caused by loss of Magel2 in a mouse model of Prader-Willi and Schaaf-Yang syndromes.
Kamaludin AA; Smolarchuk C; Bischof JM; Eggert R; Greer JJ; Ren J; Lee JJ; Yokota T; Berry FB; Wevrick R
Hum Mol Genet; 2016 Sep; 25(17):3798-3809. PubMed ID: 27436578
[TBL] [Abstract][Full Text] [Related]
10. An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.
Meziane H; Schaller F; Bauer S; Villard C; Matarazzo V; Riet F; Guillon G; Lafitte D; Desarmenien MG; Tauber M; Muscatelli F
Biol Psychiatry; 2015 Jul; 78(2):85-94. PubMed ID: 25599930
[TBL] [Abstract][Full Text] [Related]
11. Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production.
Chen H; Victor AK; Klein J; Tacer KF; Tai DJ; de Esch C; Nuttle A; Temirov J; Burnett LC; Rosenbaum M; Zhang Y; Ding L; Moresco JJ; Diedrich JK; Yates JR; Tillman HS; Leibel RL; Talkowski ME; Billadeau DD; Reiter LT; Potts PR
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32879135
[TBL] [Abstract][Full Text] [Related]
12. Loss of Magel2 impairs the development of hypothalamic Anorexigenic circuits.
Maillard J; Park S; Croizier S; Vanacker C; Cook JH; Prevot V; Tauber M; Bouret SG
Hum Mol Genet; 2016 Aug; 25(15):3208-3215. PubMed ID: 27288456
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome.
Bischof JM; Stewart CL; Wevrick R
Hum Mol Genet; 2007 Nov; 16(22):2713-9. PubMed ID: 17728320
[TBL] [Abstract][Full Text] [Related]
14. Anorexigenic melanocortin signaling in the hypothalamus is augmented in association with failure-to-thrive in a transgenic mouse model for Prader-Willi syndrome.
Ge Y; Ohta T; Driscoll DJ; Nicholls RD; Kalra SP
Brain Res; 2002 Dec; 957(1):42-5. PubMed ID: 12443978
[TBL] [Abstract][Full Text] [Related]
15. Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty.
Fountain MD; Tao H; Chen CA; Yin J; Schaaf CP
Genes Brain Behav; 2017 Jul; 16(6):592-600. PubMed ID: 28296079
[TBL] [Abstract][Full Text] [Related]
16. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
Knani I; Earley BJ; Udi S; Nemirovski A; Hadar R; Gammal A; Cinar R; Hirsch HJ; Pollak Y; Gross I; Eldar-Geva T; Reyes-Capo DP; Han JC; Haqq AM; Gross-Tsur V; Wevrick R; Tam J
Mol Metab; 2016 Dec; 5(12):1187-1199. PubMed ID: 27900261
[TBL] [Abstract][Full Text] [Related]
17. Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT
Garfield AS; Davies JR; Burke LK; Furby HV; Wilkinson LS; Heisler LK; Isles AR
Mol Brain; 2016 Dec; 9(1):95. PubMed ID: 27931246
[TBL] [Abstract][Full Text] [Related]
18. The imprinted gene Magel2 regulates normal circadian output.
Kozlov SV; Bogenpohl JW; Howell MP; Wevrick R; Panda S; Hogenesch JB; Muglia LJ; Van Gelder RN; Herzog ED; Stewart CL
Nat Genet; 2007 Oct; 39(10):1266-72. PubMed ID: 17893678
[TBL] [Abstract][Full Text] [Related]
19. Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype.
Lee S; Kozlov S; Hernandez L; Chamberlain SJ; Brannan CI; Stewart CL; Wevrick R
Hum Mol Genet; 2000 Jul; 9(12):1813-9. PubMed ID: 10915770
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.
Igarashi M; Narayanaswami V; Kimonis V; Galassetti PM; Oveisi F; Jung KM; Piomelli D
Pharmacol Res; 2017 Mar; 117():75-81. PubMed ID: 28007570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
